Skip to content

The feasibility study of sustained-release opioid used for quick analgesia

The feasibility study of sustained-release opioid used for quick analgesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TIR-17012925
Enrollment
Unknown
Registered
2017-10-10
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

Group A:use oxycodone hydrochloride controlled-release tablets for titration
Group B:use Immediate release morphine for titration

Sponsors

Department of Head and Neck/Thoracic Medical Oncology; The First People's Hospital of Foshan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. Tumor patients who was confirmed by pathology or cycology diagnosis; 3. moderate to sereve pain intensity; 4. patients with clear mind; able to understand the therapeutic regimen.

Exclusion criteria

Exclusion criteria: 1. Patients during pregnant stage and breast-feed stage; 2. Pain related to an oncologic emergency: Bone fracture or impending fracture of weight-bearing bone; Neuroaxial metastases with threatened neural injury; Infection; Obstructed or perforated viscus (acute abdomen); 3. patient with opioid contraindications; 4. patients with severe liver or kidney dysfunction (ALT/AST/creatinine/usea nitrogen was three times higher than normal value); 5. patients with a history of drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
Proportion of patients with NRS=3 during the previous 24 hours;

Secondary

MeasureTime frame
proporation of patients with a clinically meaningful (=30%) reduction of pain intensity from baseline;the NRS scores at 12h, 24h, 36h, 48h, 60h, 72h;the dose of oxycodone at 12h, 24h, 36h, 48h, 60h, 72h;the times of breakthrough pain at 12h, 24h, 36h, 48h, 60h, 72h;Assessment the quality of life in patient;Record the adverse event;Patient satisfaction assessment;

Countries

China

Contacts

Public ContactFeng Weineng

The First People's Hospital of Foshan

feng_weineng@163.com+86 18819167835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026